-
10006305-50A potent ceramidase inhibitor that induces apoptosis in human colorectal cancer, keratinocyte, and melanoma cell lines produces approximately 50% cell non-viability at 10 µM and >80% cell death at 100 µM.
-
14186-100The inactive enantiomer of L-NMMA used as a control compound to explore non-specific effects of L-NMMA.
-
14186-25The inactive enantiomer of L-NMMA used as a control compound to explore non-specific effects of L-NMMA.
-
14186-5The inactive enantiomer of L-NMMA used as a control compound to explore non-specific effects of L-NMMA.
-
17288-100A precursor in the biosynthesis of coenzyme A.
-
17288-25A precursor in the biosynthesis of coenzyme A.
-
17288-250A precursor in the biosynthesis of coenzyme A.
-
17288-50A precursor in the biosynthesis of coenzyme A.
-
18893-10A ketopentose synthesized in the pentose phosphate pathway that plays a role in the formation of various bioactive compounds.
-
18893-25A ketopentose synthesized in the pentose phosphate pathway that plays a role in the formation of various bioactive compounds.
-
18893-5A ketopentose synthesized in the pentose phosphate pathway that plays a role in the formation of various bioactive compounds.
-
18893-50A ketopentose synthesized in the pentose phosphate pathway that plays a role in the formation of various bioactive compounds.